AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnom-M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Acinom Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimnom-M 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This formulation aids in regulating blood glucose. Diabex Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, it's one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Glimnom-M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimnom-M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimnom-M 2mg/500mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medication with food.

Common Side effects of Glimnom-M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnom-M 2mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Glimnom-M 2mg/500mg Tablet with a meal.

How Glimnom-M 2mg/500mg Tablet works:

Glimepiride and Metformin 2mg/500mg tablets (Glimnom-M) offer dual action against elevated blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, acts in three ways: reducing liver glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimnom-M 2mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnom-M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glimnom-M 2mg/500mg tablets due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimnom-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. In cases of severe kidney disease, Glimnom-M 2mg/500mg tablet use is contraindicated. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnom-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimnom-M 2mg/500mg Tablet :

Should you forget a Glimnom-M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnom-M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimnom-M 2mg/500mg Tablet

Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the label or packaging. Discard any unused medication. Prevent access by children, pets, and other individuals.
Glimnom-M 2mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect is particularly risky for individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms occur, discontinue Glimnom-M 2mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimnom-M 2mg/500mg tablets, manage type 2 diabetes mellitus (DM) in adults. This dual-action therapy enhances glycemic control when coupled with a healthy diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin concurrently decreases hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 DM.
Glimnom-M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment might result in vitamin B12 deficiency.
Glimnom-M 2mg/500mg Tablet's prolonged administration is associated with Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency can lead to anemia, neurological complications including paresthesia in the extremities, muscular weakness, urinary dysfunction, cognitive impairment, and gait instability. Prophylactic Vitamin B12 supplementation, at least annually, has been proposed by some investigators to mitigate these risks.
Indeed, Glimnom-M 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This adverse effect is heightened by skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Glimnom-M 2mg/500mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimnom-M 2mg/500mg Table...
39
MRP 48
18% off